Trials / Completed
CompletedNCT01076985
Special Investigation of Kaletra in Pregnant Women
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (actual)
- Sponsor
- Abbott · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This non-interventional, post-marketing observational study was conducted to obtain safety data from the use of lopinavir/ritonavir (Kaletra), in clinical practice, in pregnant women and their children in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lopinavir/ritonavir (Kaletra) | Lopinavir/ritonavir (LPV/r) evaluated separately in patients who were naive to previous antiretroviral treatment and those who were not. |
Timeline
- Start date
- 2000-12-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-02-26
- Last updated
- 2012-01-18
- Results posted
- 2012-01-18
Locations
5 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01076985. Inclusion in this directory is not an endorsement.